-
1
-
-
0034817278
-
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience
-
Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001 28 : 555 565
-
(2001)
Urol Clin North Am
, vol.28
, pp. 555-565
-
-
Han, M.1
Partin, A.W.2
Pound, C.R.3
Epstein, J.I.4
Walsh, P.C.5
-
2
-
-
20444481754
-
Rising prostate-specific antigen after primary prostate cancer therapy
-
Ward JF, Moul JW. Rising prostate-specific antigen after primary prostate cancer therapy. Nat Clin Pract Urol 2005 2 : 174 182
-
(2005)
Nat Clin Pract Urol
, vol.2
, pp. 174-182
-
-
Ward, J.F.1
Moul, J.W.2
-
3
-
-
4143053657
-
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results
-
Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 2004 172 : 910 914
-
(2004)
J Urol
, vol.172
, pp. 910-914
-
-
Roehl, K.A.1
Han, M.2
Ramos, C.G.3
Antenor, J.A.4
Catalona, W.J.5
-
4
-
-
27244451002
-
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy
-
Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 2005 23 : 6992 6998
-
(2005)
J Clin Oncol
, vol.23
, pp. 6992-6998
-
-
Zhou, P.1
Chen, M.H.2
McLeod, D.3
Carroll, P.R.4
Moul, J.W.5
D'Amico, A.V.6
-
5
-
-
18844370372
-
Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy
-
Patel R, Lepor H, Thiel RP, Taneja SS. Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy. Urology 2005 65 : 942 946
-
(2005)
Urology
, vol.65
, pp. 942-946
-
-
Patel, R.1
Lepor, H.2
Thiel, R.P.3
Taneja, S.S.4
-
6
-
-
78649365001
-
Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy
-
D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol 2004 172 : S42 6
-
(2004)
J Urol
, vol.172
, pp. 42-6
-
-
D'Amico, A.V.1
Moul, J.2
Carroll, P.R.3
Sun, L.4
Lubeck, D.5
Chen, M.H.6
-
7
-
-
0027979775
-
Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer
-
Roach M 3rd, Marquez C, Yuo HS et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Rad Oncol Biol Phys 1994 28 : 33 7
-
(1994)
Int J Rad Oncol Biol Phys
, vol.28
, pp. 33-7
-
-
Roach III, M.1
Marquez, C.2
Yuo, H.S.3
-
8
-
-
0035003725
-
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer
-
Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clinic Proc 2001 76 : 576 581
-
(2001)
Mayo Clinic Proc
, vol.76
, pp. 576-581
-
-
Roberts, S.G.1
Blute, M.L.2
Bergstralh, E.J.3
Slezak, J.M.4
Zincke, H.5
-
9
-
-
45349084317
-
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
-
Trock BJ, Han M, Freedland SJ et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008 299 : 2760 2769
-
(2008)
JAMA
, vol.299
, pp. 2760-2769
-
-
Trock, B.J.1
Han, M.2
Freedland, S.J.3
-
10
-
-
34249940817
-
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
-
Stephenson AJ, Scardino PT, Kattan MW et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007 25 : 2035 2041
-
(2007)
J Clin Oncol
, vol.25
, pp. 2035-2041
-
-
Stephenson, A.J.1
Scardino, P.T.2
Kattan, M.W.3
-
11
-
-
0036890186
-
Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above
-
Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above. Cancer 2002 95 : 2302 2307
-
(2002)
Cancer
, vol.95
, pp. 2302-2307
-
-
Kupelian, P.A.1
Buchsbaum, J.C.2
Elshaikh, M.3
Reddy, C.A.4
Zippe, C.5
Klein, E.A.6
-
12
-
-
33745236059
-
25-year prostate cancer control and survival outcomes: A 40-year radical prostatectomy single institution series
-
Porter CR, Kodama K, Gibbons RP et al. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol 2006 176 : 569 574
-
(2006)
J Urol
, vol.176
, pp. 569-574
-
-
Porter, C.R.1
Kodama, K.2
Gibbons, R.P.3
-
13
-
-
33847414931
-
Pathologic findings at radical prostatectomy: Risk factors for failure and death
-
Swanson GP, Riggs M, Hermans M. Pathologic findings at radical prostatectomy: risk factors for failure and death. Urol Oncol 2007 25 : 110 114
-
(2007)
Urol Oncol
, vol.25
, pp. 110-114
-
-
Swanson, G.P.1
Riggs, M.2
Hermans, M.3
-
14
-
-
1842634674
-
Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles
-
Johnson CW, Anastasiadis AG, McKiernan JM et al. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles. Urol Oncol 2004 22 : 107 111
-
(2004)
Urol Oncol
, vol.22
, pp. 107-111
-
-
Johnson, C.W.1
Anastasiadis, A.G.2
McKiernan, J.M.3
-
15
-
-
58649103315
-
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial
-
Widmark A, Klepp O, Solberg A et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009 373 : 301 308
-
(2009)
Lancet
, vol.373
, pp. 301-308
-
-
Widmark, A.1
Klepp, O.2
Solberg, A.3
-
16
-
-
33751018522
-
Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial
-
Thompson IM Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006 296 : 2329 2335
-
(2006)
JAMA
, vol.296
, pp. 2329-2335
-
-
Thompson, I.M.1
Tangen, C.M.2
Paradelo, J.3
-
17
-
-
23744493443
-
Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911)
-
Bolla M, van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005 366 : 572 578
-
(2005)
Lancet
, vol.366
, pp. 572-578
-
-
Bolla, M.1
Van Poppel, H.2
Collette, L.3
|